NCT03656874: ENGAGE

Engaging Patients in Tobacco Cessation Resources in Dental Settings

Completed NA Results posted Last updated 28 June 2022

What this trial tests

NA trial testing Clinical Decision Support in Smoking in 56 participants. Completed in 30 June 2021.

Timeline

29 March 2019

Primary endpoint
30 December 2020

30 June 2021

Quick facts

Lead sponsor	HealthPartners Institute
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	56
Start date	29 March 2019
Primary completion	30 December 2020
Estimated completion	30 June 2021
Sites	3 locations across United States

Drugs / interventions tested

• Clinical Decision Support

Conditions studied

• Smoking — all drugs for Smoking →

Sponsor

HealthPartners Institute

Who can join

18 and older, any sex, with Smoking. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Percentage of Smokers With Delivery of Brief Interventions and/or Referral to Treatment Primary · within a week of the index dental encounter

Composite of provider actions reported by patient regarding delivery of brief interventions and/or referral to treatment. These actions included that the provider 1) delivered a brief smoking intervention by discussing, a)developing a quit plan or b)setting a quit date or c)using medications to help patients quit or d)discussed strategies for quitting. The provider made a 2) referral to a quitline; a)provided information about how to contact a tobacco quitline or b) arranged for the patient to be contacted by the tobacco quit line for smoking cessation. The composite is satisfied if the patien

Group	Value	95% CI
Usual Care	7
Clinical Decision Support	36

Percentage of Smokers With Initial Actions Related to Cessation Secondary · within a week of index dental encounter

Composite of patient-reported actions of smokers with initial actions related to cessation. This composite is met if the patient reported that they contacted a smoking cessation quitline, set a quit date, developed a plan to quit, or is starting nicotine replacement or other medication to help quit within 1-7 days of their index dental visit.

Group	Value	95% CI
Usual Care	3
Clinical Decision Support	20

Percentage of Smokers With Long-term Actions Related to Cessation Secondary · within six-months of index dental encounter

Composite of patient-reported actions of smokers with long-term actions related to cessation. This composite includes whether the patient reported that they quit smoking (stopped smoking for more than one day because they were trying to stop smoking), or reduced their smoking use (50% reduction in amount smoked at 6 months compared to baseline). This composite is satisfied if the patient reports that they have done any of these actions within the 6 months +/- 1 week period between the index dental visit and the date of the second patient survey.

Group	Value	95% CI
Usual Care	4
Clinical Decision Support	18

Sponsor's own description

The overarching goal of this project is to reduce smoking-associated morbidity and mortality by increasing the number of patients who are referred for tobacco cessation counseling. Using a stratified, group-randomized, controlled, 2-arm trial conducted in two settings, the investigators will compare smoking-related clinical decision support (CDS) to usual care.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

1. Interventions for tobacco cessation delivered by dental professionals.
   Holliday R, Hong B, McColl E, Livingstone-Banks J, et al · · 2021 · cited 46× · PMID 33605440 · DOI 10.1002/14651858.cd005084.pub4
2. FINDINGS AND FUTURE DIRECTIONS FROM A SMOKING CESSATION TRIAL UTILIZING A CLINICAL DECISION SUPPORT TOOL.
   Rindal DB, Kottke TE, Jurkovich MW, Asche SE, et al · · 2022 · cited 2× · PMID 36162898 · DOI 10.1016/j.jebdp.2022.101747